Table 1. The sociodemographic data of the patients.
|
Age mean (SD) (min-max) |
56.85 (11.19) (33–80) |
|
|
BMI mean (SD) median (Q1; Q3) |
28.73 (4.76) 28 (25.43; 32.22) |
|
|
Occupation n (%) |
Homemaker |
54 (66.7%) |
|
Civil servant |
11 (13.6%) |
|
|
Retired |
11 (13.6%) |
|
|
Self-employed |
5 (6.2%) |
|
|
Educational status n (%) |
Primary |
37 (45.7%) |
|
Elementary |
10 (12.3%) |
|
|
Highschool |
24 (29.6%) |
|
|
University |
10 (12.3%) |
|
|
Smoking n (%) |
Yes |
12 (14.8%) |
|
No |
69 (85.2%) |
|
|
Physical activity n (%) |
Sedentary |
1 (1.2%) |
|
Walks for pleasure |
42 (51.9%) |
|
|
Regular activity |
26 (32.1%) |
|
|
Sportive activity |
12 (14.8) |
|
|
Alcohol intake n (%) |
Yes |
12 (14.8%) |
|
No |
69 (85.2%) |
|
|
Pack years of smoking mean (SD) (min-max) |
4.56 (11.64) (0–5) |
|
|
Breast cancer diagnosis yrs. mean (SD) (min-max) |
6.01 (5.51) (0.50–22) |
|
|
Surgery n (%) |
Breast conservative surgery Mastectomy |
42 (51.9%) |
|
39 (48.1%) | ||
|
Lymph node dissection n (%) |
Yes |
45 (55.6%) |
|
No |
36 (44.4%) |
|
|
Metastasis n (%) |
Yes |
21 (25.9%) |
|
No |
60 (74.1%) |
|
|
Radiotherapy n (%) |
Yes |
66 (81.5%) |
|
No |
15 (18.5%) |
|
|
Hormonetherapy n (%) |
Yes |
63 (77.8%) |
|
No |
18 (22.2 %) |
|
|
Lymphedema duration mean (SD) (min-max) |
1.65 (2.42) (0–10) |
|
|
Lymphedema stage n (%) |
Stage 0/No clinical lymphedema* |
41 (50.6%) |
|
Stage 1 |
23 (28.4%) |
|
|
Stage 2 |
14 (17.3%) |
|
|
Stage 3 |
3 (3.7 %) |
|
n: number of patients; SD: Standard deviation; min: Minimum; Max: Maximum
*It is well established that microscopic changes occur in the lymphatic system of patients who have undergone breast cancer treatment, conferring a lifelong risk of clinical lymphedema. To emphasize this, patients with no clinical symptoms were graded as stage 0/no clinical lymphedema.